Prospera Financial Services’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,950
Closed -$36.3K 1173
2024
Q2
$36.3K Buy
+1,950
New +$36.3K ﹤0.01% 1122